News

Follow:
14060 Articles

Biogen And Alzheimer’s Disease: Too Early To Celebrate (NASDAQ:BIIB)

On July 6, 2023, the Food and Drug Administration granted full approval to Biogen (NASDAQ:BIIB) and Eisai’s (OTCPK:ESALF, OTCPK:ESAIY) anti-amyloid

By News

Eli Lilly: The Party Is Likely Over (NYSE:LLY)

Investors in Eli Lilly and Company (NYSE:LLY) have benefited from its solid execution in its well-diversified portfolio and pipeline as

By News

Burberry: Shares Move Closer To Fair Value Amid Lingering Headwinds (OTCMKTS:BBRYF)

Luxury fashion house Burberry (OTCPK:BURBY) (OTCPK:BBRYF) was facing some headwinds when I last covered it just over a year ago,

By News

Green Thumb Industries: Future Catalysts Sum Up The Bull Case (OTCMKTS:GTBIF)

Investment Thesis Green Thumb Industries (OTCQX:GTBIF) is one of the largest US multi-state operators (MSO) in the cannabis industry. They

By News

S&P, Nasdaq, Dow’s Poor Construction; T-Bill Rates, Yield Curve Creep

Listen below or on the go on Apple Podcasts and Spotify. Matthew Tuttle and Rob Isbitts dissect the S&P, Nasdaq,

By News

Crocs: Sharp Execution Delivers Astounding Results And Returns, Easily Beating SPY.

The CROX Investment Thesis Remains Excellent, Despite The Rally Thus Far CROX 3Y Stock Return Trading View Crocs, Inc. (NASDAQ:CROX)

By News

Google: 2 Ways To Generate Yield From This Growth Stock (NASDAQ:GOOG)

What's the latest on Google stock? Playing catchup in AI Have you ever seen a football play where the offense

By News

S&P 500: Improbable Top – Week Starting 10th July (SP500)

Last week's article outlined expectations for bullish continuation in the S&P 500 (SPY). With the strong close to June and

By News